Related references
Note: Only part of the references are listed.cGAS-STING signaling in cancer immunity and immunotherapy
Huashan Du et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation
Junjie Li et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Engineering precision nanoparticles for drug delivery
Michael J. Mitchell et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
STING, a promising target for small molecular immune modulator: A review
Yijun Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration
Mohamed Wehbe et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Tuning the Innate Immune Response to Cyclic Dinucleotides by Using Atomic Mutagenesis
Yao Li et al.
CHEMBIOCHEM (2020)
Multifunctional STING-Activating Mn3O4@Au-dsDNA/DOX Nanoparticle for Antitumor Immunotherapy
Min Zhou et al.
ADVANCED HEALTHCARE MATERIALS (2020)
Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer
Lei Zhou et al.
NANO LETTERS (2020)
Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel
Feihu Wang et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles
Suxin Li et al.
ACCOUNTS OF CHEMICAL RESEARCH (2020)
Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval
Duhyeong Hwang et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Expanding the space of protein geometries by computational design of de novo fold families
Xingjie Pan et al.
SCIENCE (2020)
Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity
Jingjing Liang et al.
SCIENCE ADVANCES (2020)
Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
Leila Motedayen Aval et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Polycarbonate-based ultra-pH sensitive nanoparticles improve therapeutic window
Xu Wang et al.
NATURE COMMUNICATIONS (2020)
Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic
Emily N. Chin et al.
SCIENCE (2020)
Structural basis of STING binding with and phosphorylation by TBK1
Conggang Zhang et al.
NATURE (2019)
An Analysis of the Expression and Association with Immune Cell Infiltration of the cGAS/STING Pathway in Pan-Cancer
Xiang An et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
Anping Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist
Xiaohui Zhang et al.
ACS INFECTIOUS DISEASES (2019)
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam et al.
NATURE REVIEWS MATERIALS (2019)
STING pathway agonism as a cancer therapeutic
Blake A. Flood et al.
IMMUNOLOGICAL REVIEWS (2019)
Smart cancer nanomedicine
Roy van der Meel et al.
NATURE NANOTECHNOLOGY (2019)
An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
Yang Liu et al.
NATURE COMMUNICATIONS (2019)
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
Daniel Shae et al.
NATURE NANOTECHNOLOGY (2019)
STING activation in cancer immunotherapy
Ting Su et al.
THERANOSTICS (2019)
Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy
David R. Wilson et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Identification of -Mangostin as an Agonist of Human STING
Yibo Zhang et al.
CHEMMEDCHEM (2018)
Tumor cGAMP Awakens the Natural Killers
Shriram K. Sundararaman et al.
IMMUNITY (2018)
STING Signaling Promotes Apoptosis, Necrosis, and Cell Death: An Overview and Update
Song Liu et al.
MEDIATORS OF INFLAMMATION (2018)
Design of amidobenzimidazole STING receptor agonists with systemic activity
Joshi M. Ramanjulu et al.
NATURE (2018)
STING Signaling in Cancer Cells: Important or Not?
Olga Sokolowska et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2018)
A STING-activating nanovaccine for cancer immunotherapy
Min Luo et al.
NATURE NANOTECHNOLOGY (2017)
Trafficking-Mediated STING Degradation Requires Sorting to Acidified Endolysosomes and CanBe Targeted to Enhance Anti-tumor Response
Vijay K. Gonugunta et al.
CELL REPORTS (2017)
A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists
Bowei Liu et al.
ANTIVIRAL RESEARCH (2017)
Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site
Takayuki Ohkuri et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Liposomal Delivery Enhances Immune Activation by STING Agonists for Cancer Immunotherapy
Sandeep T. Koshy et al.
ADVANCED BIOSYSTEMS (2017)
Activation of STING requires palmitoylation at the Golgi
Kojiro Mukai et al.
NATURE COMMUNICATIONS (2016)
New Developments in Liposomal Drug Delivery
Bhushan S. Pattni et al.
CHEMICAL REVIEWS (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
STING: infection, inflammation and cancer
Glen N. Barber
NATURE REVIEWS IMMUNOLOGY (2015)
A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy
Hiroko Miyabe et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Hydrolysis of 2′3′-cGAMP by ENPP1 and design of nonhydrolyzable analogs
Lingyin Li et al.
NATURE CHEMICAL BIOLOGY (2014)
Type I Interferons as Regulators of Human Antigen Presenting Cell Functions
Sandra Gessani et al.
TOXINS (2014)
Anticancer Flavonoids Are Mouse-Selective STING Agonists
Sujeong Kim et al.
ACS CHEMICAL BIOLOGY (2013)
Cyclic Dinucleotides and the Innate Immune Response
Olga Danilchanka et al.
CELL (2013)
Species-specific detection of the antiviral small-molecule compound CMA by STING
Taner Cavlar et al.
EMBO JOURNAL (2013)
Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
Joseph Conlon et al.
JOURNAL OF IMMUNOLOGY (2013)
cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING
Andrea Ablasser et al.
NATURE (2013)
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Lijun Sun et al.
SCIENCE (2013)
Block copolymer micelles for drug delivery: Design, characterization and biological significance
Kazunori Kataoka et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Polymersomes for drug delivery: Design, formation and characterization
Jung Seok Lee et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Liposomes: From a Clinically Established Drug Delivery System to a Nanoparticle Platform for Theranostic Nanomedicine
Wafa' T. Al-Jamal et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
M. Paula Longhi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Stimuli-Responsive Polymersomes as Nanocarriers for Drug and Gene Delivery
Ozana Onaca et al.
MACROMOLECULAR BIOSCIENCE (2009)
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Hiroki Ishikawa et al.
NATURE (2009)
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Hiroki Ishikawa et al.
NATURE (2008)